Загрузка...

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin

Emerging evidence suggests that dipeptidyl peptidase-4 (DPP-4) inhibitors used to treat type 2 diabetes may have nephroprotective effects beyond the reduced renal risk conferred by glycemic control. DPP-4 is a ubiquitous protein with exopeptidase activity that exists in cell membrane-bound and solub...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Sci (Lond)
Главный автор: Kanasaki, Keizo
Формат: Artigo
Язык:Inglês
Опубликовано: Portland Press Ltd. 2018
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828949/
https://ncbi.nlm.nih.gov/pubmed/29491123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20180031
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!